A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 7,494 shares of ABT stock, worth $867,355. This represents 0.07% of its overall portfolio holdings.

Number of Shares
7,494
Previous 6,151 21.83%
Holding current value
$867,355
Previous $639 Million 33.68%
% of portfolio
0.07%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $134,394 - $158,648
1,343 Added 21.83%
7,494 $854 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $11,583 - $12,930
-115 Reduced 1.84%
6,151 $639 Million
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $109,629 - $121,080
1,001 Added 19.01%
6,266 $712 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $474,850 - $581,256
5,265 New
5,265 $580 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.